Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-04

Clinical Trial Update: Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in Population [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring the therapeutic effect of isogladine maleate on NSAIDs-associated small intestinal mucosal injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isogladine maleate (isogladine maleate)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: NSAIDs-associated Intestinal Mucosal Injury | Phase 4 | Status: UNKNOWN